| 1 |
34436366 | Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation. | 2021 Aug 9 |
1 |
| 2 |
34692611 | B Lymphocyte Subsets in Children With Steroid-Sensitive Nephrotic Syndrome: A Longitudinal Study. | 2021 |
1 |
| 3 |
32777959 | Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function. | 2020 Oct |
1 |
| 4 |
27016800 | Haploidentical CD3 TCRαβ and CD19-depleted second stem cell transplant for steroid-resistant acute skin graft versus host disease. | 2016 Aug |
1 |
| 5 |
24583150 | A higher frequency of peripheral blood activated B cells in patients with non-traumatic osteonecrosis of the femoral head. | 2014 May |
1 |
| 6 |
23830064 | CD19 + CD23+ B cells, CD4 + CD25+ T cells, E-selectin and interleukin-12 levels in children with steroid sensitive nephrotic syndrome. | 2013 Jul 6 |
1 |
| 7 |
21810762 | Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery. | 2012 Mar |
2 |
| 8 |
25949374 | Peripheral CD19+ B cells are increased in children with active steroid-sensitive nephrotic syndrome. | 2009 Oct |
1 |
| 9 |
15855740 | Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. | 2005 Mar-Apr |
2 |
| 10 |
8191883 | Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. | 1994 Feb |
1 |